Cigarettes with ultralow nicotine levels are now being called the game-changer in the fight against smoking. If you are having trouble in quitting smoking, then, it is for you, that soon the Biden White House is expected to formally propose a plan that will order cigarette nicotine levels to be reduced, reports The Washington Post. For now though, it has been a failure, as these cigarettes, also known as VLN cigarettes that stands for very low nicotine are only available in 5,100 stores in 26 states. This is a very small fraction of the overall market for cigarettes. The company that makes it, 22nd Century, is struggling not because of the low supply, but also from the advocates who have long believed slashing nicotine levels altogether.

The Advent and ideation

Nicotine is a chemical that is produced naturally from tobacco that makes the cigarette and also keeps people hooked. While it is believed that it makes people alert, and get the "hit" to keep them going, it exposes the users to harmful substances, carcinogens, and increases the risk of heart disease, lung cancer, and other illness.

Ultralow-nicotine cigarettes, like the VLN brand, contain about 95% less nicotine than the regular cigarettes. The idea is quite simple: without the addictive grip of nicotine, smokers will find it easier to quit. Research too has shown some promise. For instance, the studies funded by the National Institute on Drug Abuse revealed that very low nicotine cigarettes reduced addiction potential significantly without having users to increase their smoking frequency. However, the problem is, why would anyone choose for a low-nicotine that does not make them feel the same way, when the high-nicotine cigarette is right next to it, making them feel the same way, with the same alertness, sold at the same price.

“It’s very hard to imagine someone actively choosing to continue to use a low-nicotine product for the same price when a high-nicotine product is right next to it,” said Eric Donny, a Wake Forest University School of Medicine nicotine researcher.

No wonder, the experiment with low nicotine product by Philip Morris' Next cigarettes in the 1980s and Vector Tobacco's Quest brand in the early 2000s, flopped.

FDA's Role in the Push

The Food and Drug Administration (FDA) has supported the development of such products, even allowing VLN cigarettes to be marketed as lower-risk options. However, these products remain a niche market, available in only a fraction of U.S. stores.

Recently, the Biden administration has considered a bold step—mandating a dramatic reduction in nicotine levels for all cigarettes sold in the United States. Supporters believe this move could save millions of lives, while critics, including tobacco companies, warn of potential unintended consequences.

What Could Be The Challenges?

Resistance from Big Tobacco Companies: They could argue that slashing nicotine levels could backfire. Their claim is, smokers will turn to black markets or smoke more to satisfy their cravings, which may lead to greater exposure to harmful substances.

Consumer Reluctance: History is proof to the instances of smokers being hesitant to embrace the low-nicotine products.

Political Hurdle: It may face political roadblocks, as under the Trump administration, plans to cut nicotine were shelved.

Could Low-Nicotine Cigarettes Be The Solution?

Advocates believe that ultralow-nicotine cigarettes could be a game-changer, comparing them to decaf coffee or non-alcoholic beer—products that reduce harm while offering a similar experience.

Some experts warn that a black market for traditional cigarettes could undermine these efforts. They also stress the need for safer alternatives, such as vaping products, to support smokers transitioning away from traditional cigarettes.

Even as Delhi’s H1N1 cases crossed 2,300, Director General of the Indian Council of Medical Research (ICMR) Dr. Rajiv Bahl today said there was “absolutely no cause for panic” and that seasonal influenza remains largely self-limiting.

Speaking to the media, Dr. Bahl said no new or unusual virus strain has been detected and that the rise in cases reflects expected seasonal changes.

The virus currently circulating in the country is the familiar H1N1 pdm09 strain that emerged during the 2009 pandemic and has since become a seasonal influenza virus.

The circulating Influenza A (H1N1) viruses have been identified as A/Missouri/11/2025 (H1N1) pdm09-like viruses. Hemagglutinin (HA) gene analysis places the isolates in clade 6B.1A.5a2a, subclade D.3.1.1.

Dr. Bahl said this lineage has been in continuous circulation in India since 2025. The genetic changes observed are consistent with the normal antigenic drift seen in seasonal influenza viruses.

Such minor genetic changes occur routinely as influenza viruses circulate and, by themselves, do not indicate the emergence of a new or dangerous strain.

No Urgent Need for Flu Vaccine

Dr. Bahl, who is also Secretary of the Department of Health Research (DHR), said there is no urgent need for everyone to take the flu vaccine.

He added that individuals above 65 and those who are immunocompromised may discuss vaccination with their doctors. He said that vaccination is currently only a recommendation from the WHO and is not part of the National Immunization Program.

Who Is at Higher Risk?

Seasonal influenza, including Influenza A (H1N1), is predominantly a mild and self-limiting respiratory illness in otherwise healthy individuals.

Common symptoms include:

• Fever
• Cough
• Sore throat
• Headache
• Body ache
• Fatigue and weakness

In most people, symptoms improve with supportive care, adequate rest and hydration. The presence of H1N1 does not, by itself, mean that a person will develop severe disease or require hospitalization.

However, certain groups have a higher risk of developing complications. These include:

• Elderly persons
• Young children
• Individuals with underlying medical conditions or co-morbidities
• People with compromised immunity

Dr. Bahl advised these individuals to exercise greater caution and seek timely medical advice if they develop influenza-like symptoms.

How to Prevent the Spread of Flu

Dr. Bahl advised the public to follow routine respiratory hygiene and infection-prevention measures.

Do's:

• Cover the mouth and nose while coughing or sneezing.
• Wash hands frequently with soap and water or use an appropriate hand sanitiser.
• Stay at home when unwell and avoid close contact with others.
• Maintain adequate hydration and get sufficient rest.
• Consume a healthy and balanced diet.
• Seek medical advice if symptoms are severe, persistent or worsening.
• Follow medical advice regarding testing or treatment.

Don’t:

• Do not panic because of the detection of H1N1.
• Do not take antivirals or antibiotics without medical advice.
• Avoid close contact with others while symptomatic.
• Avoid touching the eyes, nose and mouth with unwashed hands.

Stay Informed, Not Alarmed

The Ministry of Health said the public should remain “informed and vigilant, but not alarmed.”

Seasonal influenza is a familiar and routinely monitored respiratory infection. Following simple preventive measures, seeking timely medical consultation when required and avoiding unnecessary medication can help protect individuals and communities.

A massive analysis involving more than 100 million people has found strong links between recreational drug use and stroke, including among younger adults.

Stroke remains one of the world's biggest health problems and ranks as the third leading cause of death and disability combined.

The researchers found that cannabis use disorders were associated with stroke overall and were particularly linked to large artery stroke.

The study "provides compelling evidence that drugs like cocaine, amphetamines, and cannabis are causal risk factors for stroke. These findings give us stronger evidence to guide future research and public health strategies," said Dr. Megan Ritson from the Stroke Research Group at the University of Cambridge.

What Did the Study Find?

The team conducted a meta-analysis covering studies with more than 100 million participants. Their results, published in the International Journal of Stroke, showed substantial differences in stroke risk associated with several drugs.

Cocaine and amphetamine use were each linked to roughly twice the risk of stroke.

• Cocaine increased stroke risk by 96%.
• Amphetamine use was associated with a 122% increase.
• Cannabis use was associated with an increase of about 37%.
• Opioid use showed no statistically significant association with stroke risk.

Stroke Risk Was Especially High in Younger Users

The researchers separately examined people under age 55. Within this younger group, amphetamine use was associated with nearly three times the risk of stroke, an increase of 174%.

Cocaine use was associated with a 97% increase in stroke risk, while cannabis was linked to a smaller 14% increase.

Cocaine Linked to Brain Hemorrhage and Cardioembolic Stroke

Further genetic analysis revealed that cocaine use disorders were especially associated with brain hemorrhage and cardioembolic stroke.

In cardioembolic stroke, a blood clot forms in the heart and travels to the brain, blocking blood flow and causing damage to brain tissue.

According to the researchers, these genetic findings support the possibility of a causal relationship rather than an association alone.

Problematic alcohol use was also associated with an increased risk of cardioembolic stroke and large artery stroke. Alcohol addiction, meanwhile, was linked to a greater overall risk of stroke.

How Could Recreational Drugs Increase Stroke Risk?

The researchers noted several biological mechanisms that could help explain why these substances are associated with stroke. These include:

• Sudden increases in blood pressure
• Spasms and narrowing of blood vessels
• Abnormal heart rhythms
• Greater blood clotting, especially with cannabis
• Inflammation or vasculitis, particularly with amphetamines

All of these processes are already known to contribute to stroke. They can play a role in ischemic strokes, which occur when blood clots interrupt blood flow, as well as hemorrhagic strokes.

"Our analysis suggests that it is these drugs themselves that increase the risk of stroke, not just other lifestyle factors among users. Taken together, our findings emphasize the importance of public health measures to reduce substance abuse as a way of helping also reduce stroke risk," said Dr. Eric Harshfield, Alzheimer's Society Research Fellow at the Department of Clinical Neurosciences.

We often believe that depression may just result in changes in mood and behaviour. But a new study has found that major depressive disorder could disrupt production of new brain cells in the hippocampus, a region involved in memory and processing of emotions.

The study, published in Nature Medicine, analysed almost 500,000 individual brain cells from people with depression and people without the mental health condition. Researchers found changes not only in the formation of new neurons but also across the wider hippocampal circuit.

Depression May Disturb Brain’s Ability To Produce New Neurons

In the human brain, most neurons are produced before birth, but the hippocampus is one of the few regions where new neurons continue to develop even during adulthood. The researchers found that this process, known as adult hippocampal neurogenesis, stops in people with major depressive disorder.

Depression is viewed largely as a problem involving neurotransmitters such as serotonin. The new findings suggest a much more complex picture involving the brain's ability to adapt to stress and changing environments.

Maura Dupont, professor of psychiatry at Columbia University and the study's lead researcher, said, “Without the ability to create new neurons, people with depression may not have the resilience to effectively adapt to the environment."

Also read: Sugar Rationing In First 1,000 Days Linked To Lower Depression, Cancer Risk In Adulthood

The Hippocampus Links Memory With Emotional Responses

The hippocampus plays an important role in episodic memory, helping people distinguish between different experiences and connect memories with their emotional context.

Researchers say impaired neurogenesis may affect a process called pattern separation, which helps the brain keep similar experiences distinct. For instance, a friend being quiet in your company does not necessarily mean they are upset with you.

When the brain has a healthy pattern-separation system, it recognises that as an individual event rather than automatically misconstruing it and linking it to previous experiences of rejection.

Dupont said that when this ability is impaired, memories and their emotional associations can become blurred, potentially building the tendency to interpret new experiences negatively.

Also read: Lindsay Clancy Trial: What Postpartum Psychosis Really Looks Like, From A Survivor

Other Changes In Brain Changes That Extend Beyond Neuron Formation

The researchers found molecular changes across the hippocampal circuit, including genes involved in forming connections between neurons, communication between brain cells, energy production and movement of material inside cells.

The hippocampus's circuit also showed signs of inflammation and cellular stress in people with depression. This indicates that depression may involve widespread changes in how brain cells communicate and function.

What The Findings Could Mean For Depression Treatment?

The researchers say the findings could eventually help recognise different physiological effects of depression, helping develop specific treatments according to patients with different molecular structures.

Dupont said the team hopes depression could eventually be classified according to its molecular characteristics, similar to how some cancers are classified. However, the findings do not mean that depression can currently be treated by simply increasing the production of new neurons. The complete mechanism of the mental health condition is still not completely understood.